Vital Therapies, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2003-01-01
- Employees
- 51
- Market Cap
- -
Clinical Trials
17
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
- Conditions
- Acute Alcoholic Hepatitis
- First Posted Date
- 2015-11-23
- Last Posted Date
- 2019-01-25
- Lead Sponsor
- Vital Therapies, Inc.
- Target Recruit Count
- 151
- Registration Number
- NCT02612428
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸Sharp Coronado Hospital, Coronado, California, United States
🇺🇸Stanford University Medical Center, Palo Alto, California, United States
Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)
- Conditions
- Surgically-Induced Liver FailureFulminant Hepatic FailurePrimary Graft Non-FunctionAcute Liver Failure
- First Posted Date
- 2013-06-12
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Vital Therapies, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01875874
- Locations
- 🇺🇸
Keck Hospital of USC, Los Angeles, California, United States
🇺🇸Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸University of Miami Hospital, Miami, Florida, United States
To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
- Conditions
- Severe Acute Alcoholic Hepatitis
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Vital Therapies, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01829347
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸University of California San Diego, San Diego, California, United States
🇺🇸Georgetown University Hospital, Washington, District of Columbia, United States
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
- Conditions
- Acute Alcoholic Hepatitis
- First Posted Date
- 2011-11-11
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Vital Therapies, Inc.
- Target Recruit Count
- 203
- Registration Number
- NCT01471028
- Locations
- 🇺🇸
Maricopa Integrated Health System (MIHS), Phoenix, Arizona, United States
🇺🇸University of Arizona Medical Center, Tucson, Arizona, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Registry Protocol for Tracking Trial Subjects After VTI-206 Study Completion
- Conditions
- Acute Liver Failure
- Interventions
- Drug: ELAD (Extracorporeal Liver Assist System)
- First Posted Date
- 2011-10-14
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- Vital Therapies, Inc.
- Registration Number
- NCT01452295
- Prev
- 1
- 2
- Next